Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor

The aim of the present work is the development of highly efficient targeting molecules to specifically address mesoporous silica nanoparticles (MSNs) designed for the photodynamic therapy (PDT) of prostate cancer. We chose the strategy to develop a novel compound that allows the improvement of the targeting of the cation-independent mannose 6-phosphate receptor, which is overexpressed in prostate cancer. This original sugar, a dimannoside-carboxylate (M6C-Man) grafted on the surface of MSN for PDT applications, leads to a higher endocytosis and thus increases the efficacy of MSNs. View Full-TextKeywords: mannose 6-phosphate analogues; binding affinity; mesoporous silica nanoparticles; photodynamic therapy

Mots clés

mannose 6-phosphate analogues binding affinity mesoporous silica nanoparticles photodynamic therapy

Domaines

Chimie

Fichier principal

ijms-20-02809.pdf (1.7 Mo)

Origine : Fichiers produits par l'(les) auteur(s)

Odile Hennaut : Connectez-vous pour contacter le contributeur

https://hal.umontpellier.fr/hal-02180471

Soumis le : jeudi 11 juillet 2019-14:33:39

Dernière modification le : jeudi 11 avril 2024-13:08:13

Dates et versions

hal-02180471 , version 1 (11-07-2019)

Licence

Paternité

Identifiants

HAL Id : hal-02180471 , version 1
DOI : 10.3390/ijms20112809

Citer

Elise Bouffard, Chiara Mauriello Jimenez, Khaled El Cheikh, Marie Maynadier, Ilaria Basile, et al.. Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor. International Journal of Molecular Sciences, 2019, 20 (11), pp.2809. ⟨10.3390/ijms20112809⟩. ⟨hal-02180471⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS ICG INC-CNRS CHIMIE UNIV-MONTPELLIER

46 Consultations

79 Téléchargements